Health ❯ Obesity ❯ Treatment Options

Oral Medications

GLP-1 Drugs Foundayo FDA Approval Patient Adherence Patient Preferences Drug Efficacy GLP-1 Agonists Wegovy Pill GLP-1 Therapies Market Expansion

Novo Nordisk Lifts Outlook After Wegovy Pill Powers Big Q1 Beat

Early uptake points to market expansion with first‑time users driving pill demand.

Pfizer Licenses Early-Stage Oral GLP-1 From YaoPharma in Up to $2 Billion Deal

Structure Therapeutics' Oral GLP-1 Posts Up to 15% Placebo-Adjusted Weight Loss as Company Prepares Phase 3

Viking’s Oral Obesity Pill Shows Strong Weight Loss but High Dropouts, Triggering Stock Rout